Implanted tile-based radiation shows promise compared with stereotactic radiotherapy for brain metastases

Lorlatinib delivers 7-year progression-free survival and durable brain control in ALK+ NSCLC

ASCO 2026: Latest updates in mRCC

Adagloxad simolenin plus OBI-821 shows no survival benefit compared to standard of care in triple-negative breast cancer

ASCO 2026: Breast cancer overview

mRNA-4359 plus pembrolizumab shows high response rates and robust T-cell activation in melanoma

Combination therapeutic strategies for aRCC patients with bone metastases

Is radiotherapy a back up plan after neoadjuvant chemo-immunotherapy in perioperative lung cancer management?

Part 1: Why test?

Part 2: How to get biopsies for testing?

Part 3: Managing testing efficiencies – How to optimise next generation sequencing and HRR testing

Part 4: Clinical decision making - Interpretation of next generation sequencing results